Search clinical trials for: Ruxolitinib plus simvastatin
Total 5673 results
-
Fundación de investigación HMApices Soluciones S.L.Completed
-
Organon and CoMerck Sharp & Dohme LLCCompletedAtherosclerosis | Hypercholesterolemia | Hyperlipoproteinemia Type II
-
Provident Clinical ResearchReliant PharmaceuticalsCompleted
-
University of Sao PauloCompletedCoronary Heart Disease
-
University of CologneMerck Sharp & Dohme LLCCompleted
-
First Affiliated Hospital of Zhejiang UniversityXiangya Hospital of Central South University; Second Affiliated Hospital, School... and other collaboratorsRecruitingHematologic Malignancy | Bronchiolitis Obliterans SyndromeChina
-
Novartis PharmaceuticalsTerminatedMyelofibrosis With High Molecular Risk MutationsBelgium, Spain, United Kingdom, Hungary, Italy, Japan, Taiwan, Germany, Canada, Singapore, Austria, Australia, France, Israel, Sweden, Switzerland, Hong Kong, Greece, Turkey, Brazil, Russian Federation, Denmark, Portugal, Norway, Poland
-
Merck Sharp & Dohme LLCCompleted
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São PauloUnknown
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research ConsortiumRecruitingDuctal Carcinoma In Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia | Lobular Carcinoma In SituUnited States
-
Fasa University of Medical SciencesShiraz University of Medical SciencesCompletedPolycystic Ovary SyndromeIran, Islamic Republic of
-
Incyte CorporationActive, not recruiting
-
Ain Shams UniversityCompletedMetabolic Syndrome | Chronic Hepatitis cEgypt
-
Beijing Friendship HospitalUnknownHemophagocytic LymphohistiocytosisChina
-
University of OxfordNational Health and Medical Research Council, Australia; Merck Sharp & Dohme... and other collaboratorsCompleted
-
Juan A. ArnaizCompletedCirrhosis | Hypertension, Portal | Portal Vein Thrombosis | Bleeding Esophageal VaricesSpain
-
Children's Hospital Medical Center, CincinnatiRecruitingBronchiolitis Obliterans (BO) | Hematopoietic Stem Cell Transplant (HSCT)United States
-
University of JenaCompleted
-
University of Michigan Rogel Cancer CenterCompletedHemophagocytic Syndrome (HPS)United States
-
Margherita MaffioliUnknown
-
University of PittsburghWithdrawnHead and Neck Squamous Cell Carcinoma
-
Tel-Aviv Sourasky Medical CenterUnknownPachyonychia Congenita
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Artery Disease | Atherosclerosis | Carotid Artery DiseasesUnited States, Canada
-
Sichuan UniversityNot yet recruitingGVHD | Acute Stem Cell Transplant ComplicationsChina
-
Multinational Center for Quality of Life Research...Not yet recruiting
-
University of RochesterIncyte CorporationCompletedDiscoid Lupus ErythematosusUnited States
-
Tianjin Medical University General HospitalWithdrawnNeuromyelitis Optica Spectrum Disorder RelapseChina
-
Qilu Hospital of Shandong UniversityCompleted
-
Novartis PharmaceuticalsCompletedPrimary Myelofibrosis | Post-Essential Thrombocythemia Myelofibrosis | Post-Polycythemia Vera-MyelofibrosisBelgium, Italy, Spain, Bulgaria, Turkey, Greece, Russian Federation, Austria, Canada, Japan, Germany
-
Kantonsspital AarauNovartis; University Hospital, Basel, Switzerland; Clinical Trial Unit, University...TerminatedCancer CachexiaSwitzerland
-
National Heart, Lung, and Blood Institute (NHLBI)RecruitingSevere Aplastic Anemia | Single Lineage Cytopenias, T-LGL | Hypoplastic MDSUnited States
-
Qilu Hospital of Shandong UniversityRecruiting
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute; Thomas Jefferson University; Cornell UniversityRecruiting
-
Children's Hospital Medical Center, CincinnatiCompletedSolid Organ Transplant | Acute-graft-versus-host Disease | Chronic Graft-versus-host-diseaseUnited States
-
University of RochesterIncyte CorporationActive, not recruiting
-
Aaron R. MangoldCompletedNecrobiosis LipoidicaUnited States
-
Novartis PharmaceuticalsTerminatedPrimary MyelofibrosisSpain, Germany, Italy
-
University of CopenhagenCompletedCardiovascular Disease | Diabetes MellitusDenmark
-
Stefanie Sarantopoulos, MD, PhD.National Institutes of Health (NIH); Incyte Corporation; Rigel PharmaceuticalsNot yet recruitingChronic Graft Versus Host DiseaseUnited States
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; Incyte CorporationRecruitingMyelofibrosis Due to and Following Polycythemia VeraUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingT-cell Large Granular Lymphocyte Leukemia | T-cell Lymphomas | T-cell Prolymphocytic Leukemia | NK-Cell LymphomasUnited States
-
Novartis PharmaceuticalsActive, not recruitingGraft vs Host DiseaseJapan, Slovakia, Taiwan, Spain, Korea, Republic of, Thailand, Canada, Russian Federation, Italy, Turkey, India, Czechia, Brazil, Switzerland
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)United States
-
Columbia UniversityLocks of Love; Alopecia Areata Initiative - Gates FoundationCompletedAlopecia AreataUnited States
-
Novartis PharmaceuticalsCompletedMyelofibrosisBelgium, Colombia, Canada, Italy, Spain, Austria, Germany, Czechia, Thailand, Hungary, Greece, Argentina, Brazil, Israel, Russian Federation, Mexico, Portugal, South Africa, Tunisia, Slovakia, Saudi Arabia, Poland, Algeria, Ireland, Mor...
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
National Cancer Center, KoreaActive, not recruitingSmall Cell Lung CarcinomaKorea, Republic of
-
Novartis PharmaceuticalsRecruitingGraft-versus-Host DiseaseKorea, Republic of
-
Massachusetts General HospitalIncyte CorporationRecruitingPolycythemia Vera | Essential ThrombocythemiaUnited States